Bioengineering researchers at the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) have developed a soft, thin, stretchable bioelectronic device that can be implanted into a tadpole embryo’s brain and record electrical activity with no impact on normal tadpole embryo development or behavior. This novel device could help researchers better understand and treat diseases that manifest in early brain development.

Investigating the reasons behind the stall in the decline of cardiovascular disease deaths in the U.S. and the new scientific innovations emerging from Harvard labs that aim to improve treatment and drive death rates down.

A recent feature in The Harvard Crimson highlights how OTD has ensured that innovations created in Harvard labs reach real-world applications, improving lives and shaping our future.

With funding and business development support from the Blavatnik Biomedical Accelerator, a research team’s lab discovery propelled to startup success.